Yuflyma

1 minute read

Business

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with…

byKarren

July 18, 2022

The Latest

MediKarma Acquires Nanell from Niterra Co., Ltd. to Accelerate Women’s Health Expansion and Value-Based Care Footprint

SheltonAI Announces Ali Tariq as Head of Middle East

Asana Now Available in the AWS Middle East (UAE) Region to Support Enterprise and Government Customers with Local Data Residency

Arabian Ethicals Leads Global Discussion on Cell and Gene Therapy at WHX Dubai 2026

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

MediKarma Acquires Nanell from Niterra Co., Ltd. to Accelerate Women’s Health Expansion and Value-Based Care Footprint

SheltonAI Announces Ali Tariq as Head of Middle East

Asana Now Available in the AWS Middle East (UAE) Region to Support Enterprise and Government Customers with Local Data Residency

Arabian Ethicals Leads Global Discussion on Cell and Gene Therapy at WHX Dubai 2026

AHS Tower Fully Sold During Development, Generating More Than USD 700 Million

NAFFCO Group and MAN Truck & Bus Strengthen Strategic Partnership with Expanded MoU

Al Tamimi and Company Appoints Graham de Guise as Chief People Officer

iCAUR V27 Makes Its First Global Launch In The UAE